Researchers will analyze nearly 200 patients at 30 sites throughout the United States.
Here are five takeaways:
1. The study is a prospective, randomized, active treatment-controlled evaluator-binded multicenter study.
2. The study aims to establish that hyaluronan-based scaffold with autologous bone marrow aspirate concentrate is the best treatment for articular knee cartilage defect lesions.
3. Anika Therapeutics’ HYALOFAST is a biodegradable scaffold that facilitates cartilage regeneration in patients with cartilage defects.
4. In Europe, patients treated with HYALOFAST successfully regenerated hyaline-like cartilage.
5. Anika Therapeutics specializes in therapeutics based on its proprietary hyaluronic acid technology.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. Matthew Beal of Northwestern Medicine
Orthofix shares witness high volume increase: 5 facts
Distracted walking causes more injuries and hospital visits — 5 takeaways
